Biomarkers of Inflammatory Bowel Disease

被引：63

作者：

Yi Fengming ^{[1
]}

Wu Jianbing ^{[1
]}

机构：

[1] Nanchang Univ, Affiliated Hosp 2, Dept Oncol, Nanchang 330006, Jiangxi, Peoples R China

来源：

DISEASE MARKERS | 2014年 / 2014卷

关键词：

SACCHAROMYCES-CEREVISIAE ANTIBODIES; ACTIVE ULCERATIVE-COLITIS; FECAL PYRUVATE-KINASE; MEAN PLATELET VOLUME; C-REACTIVE PROTEIN; CROHNS-DISEASE; INTESTINAL INFLAMMATION; NONINVASIVE MARKER; DIAGNOSTIC-VALUE; INDETERMINATE COLITIS;

D O I：

10.1155/2014/710915

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Inflammatory bowel disease (IBD) is a chronic disease mostly involved with intestine with unknown etiology. Diagnosis, evaluation of severity, and prognosis are still present as challenges for physicians. An ideal biomarker with the characters such as simple, easy to perform, noninvasive or microinvasive, cheap, rapid, and reproducible is helpful for patients and clinicians. Currently biomarkers applied in clinic include CRP, ESR, pANCA, ASCA, and fecal calprotectin. However, they are far from ideal. Lots of studies are focused on seeking for ideal biomarker for IBD. Herein, the paper reviewed recent researches on biomarkers of IBD to get advances of biomarkers in inflammatory bowel disease.

引用

页数：11

共 50 条

[41] Circulating Protein Signatures As Biomarkers for Inflammatory Bowel Disease Management
Viennois, Emilie
Baker, Mark
Xiao, Bo
Ayyadurai, Saravanan
Laroui, Hamed
Merlin, Didier
GASTROENTEROLOGY, 2014, 146 (05) : S422 - S422
[42] Biomarkers Predictive of Response to Thiopurine Therapy in Inflammatory Bowel Disease
Cornish, Jack S.
Wirthgen, Elisa
Daebritz, Jan
FRONTIERS IN MEDICINE, 2020, 7
[43] Do biomarkers help to optimize therapy in inflammatory bowel disease?
Vermeire, S.
IMMUNOREGULATION IN INFLAMMATORY BOWEL DISEASES - CURRENT UNDERSTANDING AND INNOVATION, 2007, 153 : 55 - 60
[44] Biomarkers in inflammatory bowel disease: current practices and recent advances
Iskandar, Heba N.
Ciorba, Matthew A.
TRANSLATIONAL RESEARCH, 2012, 159 (04) : 313 - 325
[45] Raman spectroscopic molecular fingerprinting of biomarkers for inflammatory bowel disease
Buchan, Emma
Rickard, Jonathan James Stanley
Oppenheimer, Pola Goldberg
CLINICAL AND TRANSLATIONAL MEDICINE, 2023, 13 (11):
[46] Myostatin and Activin A as Biomarkers of Sarcopenia in Inflammatory Bowel Disease Patients
Godala, Malgorzata
Gaszynska, Ewelina
Walczak, Konrad
Malecka-Wojciesko, Ewa
NUTRIENTS, 2024, 16 (06)
[47] Fecal biomarkers in inflammatory bowel disease: how, when and why?
Ministro, Paula
Martins, Diana
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (04) : 317 - 328
[48] Serum biomarkers confirming stable remission in inflammatory bowel disease
Kessel, Christoph
Lavric, Miha
Weinhage, Toni
Brueckner, Markus
de Roock, Sytze
Daebritz, Jan
Weber, Jakob
Vastert, Sebastiaan J.
Foell, Dirk
SCIENTIFIC REPORTS, 2021, 11 (01)
[49] Pharmacotranscriptomic Biomarkers in Glucocorticoid Treatment of Pediatric Inflammatory Bowel Disease
Lucafo, Marianna
Stankovic, Biljana
Kotur, Nikola
Di Silvestre, Alessia
Martelossi, Stefano
Ventura, Alessandro
Zukic, Branka
Pavlovic, Sonja
Decorti, Giuliana
CURRENT MEDICINAL CHEMISTRY, 2018, 25 (24) : 2855 - 2871
[50] Bone turnover biomarkers alteration in patients with Inflammatory Bowel Disease
Omran, S.
Eldeen, H. Gamal
Latif, Z. Abdel
Abdou, D.
Hamdy, R.
Gaber, A.
Ali, A.
Shehab, H.
El Raziky, M.
JOURNAL OF CROHNS & COLITIS, 2025, 19 : I918 - I918

← 1 2 3 4 5 →